{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-23-000121","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.033725+00:00","generated_at":"2026-06-08T09:04:58.023251+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"OrthoPediatrics amends Bylaws to adopt universal proxy card rules and enhance disclosure","bullets":["Board approved amended and restated Bylaws effective November 2, 2023.","Requires stockholder nominating directors to comply with Rule 14a-19 and provide evidence of compliance.","Enhances disclosure requirements for stockholder proposals and director nominations.","Includes technical and conforming changes to align with SEC rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-23-000121","json":"https://secwatch.observer/filing/0001425450-23-000121.json","markdown":"https://secwatch.observer/filing/0001425450-23-000121.md","text":"https://secwatch.observer/filing/0001425450-23-000121.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000121/0001425450-23-000121-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000121/kids-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T09:04:58.023251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da35209c253d2e1a407b94f2dfd21b1980550e82","claim":"ORTHOPEDIATRICS CORP: Amended and restated Bylaws to adopt universal proxy card rules under Rule 14a-19 and enhance disclosure requirements for director nominations and stockholder proposals (effective 2023-11-02).","evidence_excerpt":"On November 2, 2023, the Board of Directors (the “Board”) of OrthoPediatrics Corp. (the “Company”) approved and adopted, effective as of such date, amended and restated Bylaws (as so amended and restated, the “Bylaws”). The Bylaws amend and restate the Company’s prior bylaws in their entirety to, among other things, address the adoption by the U.S. Securities and Exchange Commission of new “universal proxy card” rules, as set forth in newly adopted Rule 14a-19 of the Exchange Act (“Rule 14a-19”) in order to ensure that, from a procedural and mechanical perspective, the Bylaws function properly in the case of a contested election using a new universal proxy card.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000121/0001425450-23-000121-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-11-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}